 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
GSK to axe 620 jobs in Kent
|
11-Nov-2008
|
GlaxoSmithKline, the world’s second largest pharmaceutical company proposes to close its manufacturing site in Dartford, Kent with the loss of 620 jobs
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
GSK to acquire Genelabs Technologies
|
30-Oct-2008
|
GlaxoSmithKline and Genelabs Technologies have announced that they have entered into a definitive agreement for GSK to acquire the US-based biotech company Genelabs for approximately $57m
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
Credit crunch hits R&D
|
27-Oct-2008
|
The global credit crunch could jeopardise the near-term development of innovative medicines by pharmaceutical companies and biotech firms, according to experts
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
PPRS changes delayed
|
23-Oct-2008
|
The Department of Health has postponed the date on which pharmaceutical companies will be required to reduce the price of its non-exclusive medicines
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
Slippery slope
|
16-Oct-2008
|
With the UK economy now officially in recession, politicians and business leaders are concerned that the country could slide into a depression not seen since the 1930s
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
Lilly claims ImClone
|
14-Oct-2008
|
Alaska Acquisition, a wholly-owned subsidiary of Eli Lilly &Co, has made an offer of $70 net per share for all outstanding shares of ImClone Systems
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
Credit crunch
|
13-Oct-2008
|
Companies that provide confidential support and guidance are less likely to feel the pressure of personal debt stress
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
GMS contract held to account
|
09-Oct-2008
|
The first three years of the General Medical Services contract, implemented in April 2004, cost the UK’s Department of Health £1.8bn more than expected
Read more...
|
|
 |
 |
 |
|
WPP offer for TNS accepted
|
09-Oct-2008
|
Following WPP’s refusal to raise its hostile £1.1bn bid for TNS, WPP announced on October 8, 2008, valid acceptances of the offer had been received
Read more...
|
|
 |
 |
 |
|
Job losses at Genmab
|
08-Oct-2008
|
Danish pharma company Genmab has announced that it will be reducing its workforce by 100 across its international locations
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |
|
Charities not in the pocket of pharma
|
01-Oct-2008
|
Patient groups and healthcare charities whose existence and good work relies on donations from individuals and organisations have denied that they are in any way obliged to fight the pharmaceutical industry’s corner
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
Pfizer cuts back on R&D
|
01-Oct-2008
|
Pfizer is significantly revamping its R&D pipeline, getting rid of development programmes in a number of areas in order to focus on others
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
ADHD warning letters
|
30-Sep-2008
|
The US Food and Drug Administration has issued warning letters objecting to marketing tactics for Shire’s Adderall XR and Lilly’s Strattera
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
Report criticises pharma prices
|
30-Sep-2008
|
AARP has issued a new report criticizing the pharma industry for a sharp rise in prices on the 144 specialty drugs most commonly used by people enrolled in the Medicare drug benefit
Read more...
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
 |
 |